We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App

Blood Tests Can Help Physicians Correctly Diagnose Alzheimer's In Low-Resource Environments

By LabMedica International staff writers
Posted on 25 Apr 2023
Print article
A set of blood tests used in combination with memory tests can correctly diagnose Alzheimer’s (Photo courtesy of Freepik)
A set of blood tests used in combination with memory tests can correctly diagnose Alzheimer’s (Photo courtesy of Freepik)

In low-resource communities, which are home to 58% of the global dementia population, there is often a shortage of specialists capable of diagnosing Alzheimer's disease or access to brain imaging equipment for confirmation. Although spinal fluid biomarkers can confirm a diagnosis, patients might be hesitant to undergo a lumbar puncture to extract cerebrospinal fluid. Recently, blood-based biomarkers have emerged as a viable alternative, performing nearly as well as spinal fluid biomarkers in identifying Alzheimer's disease. However, limited research has been conducted in low-resource settings to evaluate the accuracy of these blood tests for diagnosing Alzheimer's disease. Now, neurologists are investigating a combination of blood tests and memory assessments to enhance diagnostic accuracy in these environments.

In a collaborative study between Columbia University (New York, NY, USA) and local physicians, 746 older adults (average age of 71) were recruited from the Dominican Republic and the Dominican community in northern Manhattan. Participants underwent extensive neurological and cognitive evaluations, with a panel of Columbia neurologists specializing in Alzheimer's diagnosis analyzing the results to determine if participants had Alzheimer's, other forms of dementia, or normal cognitive aging. Blood samples were collected to measure Alzheimer's blood-based biomarkers. Just over 20% of participants were clinically diagnosed with Alzheimer's, and their blood tests revealed elevated levels of Alzheimer's biomarkers, including phosphorylated tau, neurofilament light chain, and glial fibrillary acidic protein.

Interestingly, the blood-based tests also appeared to detect early biological signs of Alzheimer's before symptoms manifest. Approximately 20% of participants who were not diagnosed with Alzheimer's based on memory and cognitive assessments displayed elevated levels of the aforementioned biomarkers in their blood. This suggests that blood tests may be a sensitive indicator of preclinical Alzheimer's disease, potentially benefiting early intervention efforts as preventive strategies become more readily available. Further research is needed to determine the clinical applications of blood-based biomarker tests, as they are not currently available outside of research studies.

“Alzheimer’s disease is one form of dementia and as more treatments emerge, developing an accurate blood test will be essential in finding people who will benefit from treatment, particularly those who lack access to more advanced diagnostic tools,” said Richard Mayeux, MD, chair of the Department of Neurology at Columbia University Vagelos College of Physicians and Surgeons and one of the study’s senior authors.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article



view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more


view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more


view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.